| Execution period | Financial Year 2025-2026 |
|---|
NSE filing, NSE: BIOPOL. Summary written from the filing by ALFA Finder's alert engine.
Biopol Chemicals Ltd: key numbers
- Share price
- ₹44.00
- Market cap
- ₹47.54 Cr
- Revenue (annual)
- ₹81.14 Cr
- Net profit (annual)
- ₹8.97 Cr
- P/E (TTM)
- 5.3×Sector 34.1×
- Promoter holding
- 65.81%+0.00% QoQ
- FII holding
- 0.47%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biopol Chemicals Ltd
All →Biopol Chemicals Board Meeting Date
Biopol Chemicals Limited scheduled a board meeting for November 5, 2026, to consider and approve its unaudited standalone financial results for the half-year ending September 2026.
Biopol Chemicals Other Announcement
Biopol Chemicals Limited has intimated the exchange regarding the non-applicability of the Corporate Governance Report for the quarter ended September 30, 2026.
Biopol Chemicals Management Change
Biopol Chemicals Limited regularised the appointment of Mr. Sukhomoy Das as an Independent Director for a five-year term, effective June 11, 2026, following shareholder approval.
Biopol Chemicals Annual General Meeting
Biopol Chemicals Limited held its 3rd Annual General Meeting on September 22, 2026, via video conferencing. The meeting transacted ordinary and special business items.
Biopol Chemicals Business Update
Biopol Chemicals Limited participated in the 53rd Dye+Chem Bangladesh 2026 International Expo held in Dhaka from September 2 to September 5, 2026.
Biopol Chemicals Price Movement Clarification
Biopol Chemicals Limited clarified that recent share price movements are entirely market-driven. The company confirmed it has no undisclosed material information affecting trading volume or price.
Other board meeting outcome announcements
All →R R Kabel Board Meeting Outcome
RR Kabel's board approved amendments to its UPSI fair disclosure code on 28 October 2026. The amended code is enclosed and posted on the company website.
M K Exim (India) Board Meeting Outcome
M.K. Exim (India) approved shifting its registered office within Jaipur to Plot J-1247, Sitapura. The board meeting was held on October 28, 2026.
United Spirits Board Meeting Outcome
United Spirits' board approved amendments to its insider trading code on 28 October 2026, effective 29 October 2026. The revised code is available on the company website.
SBI Funds Management Board Meeting Outcome
SBI Funds Management extended internal auditor Chhajed & Doshi's term to March 31, 2030. This routine decision was taken at the October 28, 2026 board meeting.
- Execution
- April 1, 2028 to March 31, 2030
Paras Healthcare Board Meeting Outcome
Paras Healthcare filed its board-approved UPSI fair disclosure code under Regulation 8(2). This routine governance policy update reports no business event.
Gateway Distriparks Board Meeting Outcome
Gateway Distriparks' board approved a revised Code of Practices for Fair Disclosure of UPSI under PIT Regulation 8(2). This is a routine governance policy update with no business event.